Individualized Therapies Workshop - 2763 Peter Marks (at podium), , Director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration On March 3, 2020, Dr. Marks hosted a first-of-its-kind public workshop around gene therapies and phage therapies, to foster the development of individualized therapeutic products for the treatment of an individual or for very small numbers of patients.


Size: 5066px × 3377px
Photo credit: © 2020 Images / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: